Dr. Narasimhan Mani
CM3 Advisory
66
9
Market Capitalization2
16.62M
Enterprise Value
13.08M
Enterprise Value/EBITDA(ttm)
-0.34
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.23
Price to Cash(ytd)
--
Gross Margin(ttm)
84.38%
Operating Margin(ttm)
--
Profit Margin(ttm)
2504.29%
Return on Equity(ttm)
-56.28%
Return on Invested Capital(ttm)
-58.02%
Return on Assets(ttm)
-44.76%
Revenue(ttm)
477.70K
Revenue Per Share(ttm)
0.01
Gross Profit(ttm)
384.70K
EBITDA(ttm)3
-38.93M
Net Income Available to Common(ttm)
-41.85M
Diluted EPS(ttm)
-2.51
Beta (5Y Monthly)
3.26
52-Week Change
-80.52%
S&P 500 52-Week Change
21.42%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
40.63M
Dividend Yield
0.00%
Float4
31.94M
% Held by Insiders
21.39%
% Held by Institutions
5.68%
Total Cash(mrq)
3.54M
Total Cash Per Share(mrq)
0.09
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
1.70%
Quick Ratio(mrq)
1.63%
Book Value Per Share(mrq)
1.64
Operating Cash Flow Per Share(ytd)
-0.07
Free Cash Flow(ytd)
-2.92M
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.